<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The intra-arterial administration of nimodipine (IAN) is commonly used for <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> refractory to medical treatments </plain></SENT>
<SENT sid="1" pm="."><plain>We report two cases of vasogenic <z:hpo ids='HP_0000969'>edema</z:hpo> after IAN </plain></SENT>
<SENT sid="2" pm="."><plain>Our patients with aneurismal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> presented with vasospasm, which was treated by IAN </plain></SENT>
<SENT sid="3" pm="."><plain>Consequently, vasogenic <z:hpo ids='HP_0000969'>edema</z:hpo> developed in the basal ganglia </plain></SENT>
<SENT sid="4" pm="."><plain>Reperfusion following IAN for vasospasm may have the potential for inciting vasogenic <z:hpo ids='HP_0000969'>edema</z:hpo> in the ischemic brain </plain></SENT>
</text></document>